Neovacs
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
Description
Neovacs is a biotechnology company with two main activities: research and development, and investment. The company's R&D focuses on its proprietary Kinoid technology platform, an active immunotherapy approach for treating autoimmune diseases and allergies. This technology develops therapeutic vaccines designed to stimulate the patient's immune system to regulate the overproduction of harmful cytokines. Key indications for its Kinoid products include lupus. In addition to its internal development, Neovacs invests in high-potential BioTech and MedTech companies, leveraging its experienced team to evaluate and support innovative products and medical devices.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-13 18:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 240.2 KB | ||
| 2023-11-10 08:00 |
Néovacs présentera les derniers résultats de son candidat vaccin kinoïde IgE lo…
|
French | 236.4 KB | ||
| 2023-11-06 08:00 |
Néovacs a présenté les derniers résultats sur ses candidats-vaccins ciblant les…
|
French | 239.4 KB | ||
| 2023-10-31 23:30 |
Résultats semestriels 2023
|
French | 266.9 KB | ||
| 2023-10-30 18:00 |
Néovacs confirme son éligibilité au PEA-PME
|
French | 223.9 KB | ||
| 2023-10-23 08:00 |
La perspective d'un contrat majeur pour Pharnext valide la stratégie d'investis…
|
French | 236.8 KB | ||
| 2023-10-10 18:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 158.4 KB | ||
| 2023-10-02 22:00 |
Ajustement de la valeur nominale
|
French | 145.8 KB | ||
| 2023-09-15 18:00 |
Levée de fonds de 0,5 MEUR
|
French | 234.4 KB | ||
| 2023-09-06 18:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 157.9 KB | ||
| 2023-09-04 20:00 |
Ajustement de la valeur nominale
|
French | 147.0 KB | ||
| 2023-08-01 18:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 156.7 KB | ||
| 2023-07-24 18:00 |
Succès de la campagne d''adhésion à la fiducie et début de l''equitization des …
|
French | 235.5 KB | ||
| 2023-07-10 08:00 |
Les derniers résultats des candidats-vaccins contre l'asthme ont été présentés …
|
French | 220.6 KB | ||
| 2023-07-07 08:00 |
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 155.9 KB |
Automate Your Workflow. Get a real-time feed of all Neovacs filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neovacs
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neovacs via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
